PNU 183792

Drug Profile

PNU 183792

Alternative Names: PHA-183792

Latest Information Update: 15 Jul 2011

Price : $50

At a glance

  • Originator Pfizer
  • Class Antivirals
  • Mechanism of Action RNA polymerase I inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Herpesvirus infections

Most Recent Events

  • 15 Jul 2011 Discontinued - Preclinical for Herpesvirus infections in USA (PO)
  • 04 Aug 2009 No development reported - Preclinical for Herpesvirus infections in USA (PO)
  • 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top